Cite

HARVARD Citation

    Alayed, Y. et al. (2018). Dose escalation for prostate stereotactic ablative radiotherapy (SABR): Late outcomes from two prospective clinical trials. Radiotherapy and oncology. 127 (2), pp. 213-218. [Online]. 
  
Back to record